1. Home
  2. IMNM vs METC Comparison

IMNM vs METC Comparison

Compare IMNM & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • METC
  • Stock Information
  • Founded
  • IMNM 2006
  • METC 2015
  • Country
  • IMNM United States
  • METC United States
  • Employees
  • IMNM N/A
  • METC N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • METC Coal Mining
  • Sector
  • IMNM Health Care
  • METC Energy
  • Exchange
  • IMNM Nasdaq
  • METC Nasdaq
  • Market Cap
  • IMNM 945.8M
  • METC 1.1B
  • IPO Year
  • IMNM 2020
  • METC 2017
  • Fundamental
  • Price
  • IMNM $10.30
  • METC $23.53
  • Analyst Decision
  • IMNM Strong Buy
  • METC Strong Buy
  • Analyst Count
  • IMNM 7
  • METC 3
  • Target Price
  • IMNM $24.57
  • METC $21.67
  • AVG Volume (30 Days)
  • IMNM 629.1K
  • METC 3.7M
  • Earning Date
  • IMNM 08-06-2025
  • METC 07-31-2025
  • Dividend Yield
  • IMNM N/A
  • METC 2.34%
  • EPS Growth
  • IMNM N/A
  • METC N/A
  • EPS
  • IMNM N/A
  • METC N/A
  • Revenue
  • IMNM $12,589,000.00
  • METC $625,919,000.00
  • Revenue This Year
  • IMNM N/A
  • METC N/A
  • Revenue Next Year
  • IMNM $154.73
  • METC $24.78
  • P/E Ratio
  • IMNM N/A
  • METC N/A
  • Revenue Growth
  • IMNM 16.74
  • METC N/A
  • 52 Week Low
  • IMNM $5.15
  • METC $5.90
  • 52 Week High
  • IMNM $16.73
  • METC $27.31
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 53.80
  • METC 56.81
  • Support Level
  • IMNM $9.37
  • METC $19.94
  • Resistance Level
  • IMNM $10.39
  • METC $27.31
  • Average True Range (ATR)
  • IMNM 0.49
  • METC 2.10
  • MACD
  • IMNM -0.06
  • METC -0.43
  • Stochastic Oscillator
  • IMNM 52.81
  • METC 54.46

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: